← FDA Drug Approvals (Drugs@FDA)
BRINZOLAMIDE; BRIMONIDINE TARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PERRIGO PHARMA INTERNATIONAL DAC · Approved 2023-11-29
Drug application
- FDA Application #
ANDA212137- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BRINZOLAMIDE; BRIMONIDINE TARTRATE
- Generic name
- Brinzolamide
- Active ingredients
- BRINZOLAMIDE; BRIMONIDINE TARTRATE
- Dosage form
- SUSPENSION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- None (Tentative Approval)
- Sponsor
- PERRIGO PHARMA INTERNATIONAL DAC
- First approval
- 2023-11-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown